Wedbush Upgrades Diebold (DBD) to Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts DBD Hot Sheet
Price: $56.05 +1.82%
Rating Summary:
6 Buy, 7 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 23 | Down: 26 | New: 23
Rating Summary:
6 Buy, 7 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 23 | Down: 26 | New: 23
Join SI Premium – FREE
Wedbush analyst Matt Bryson upgraded Diebold (NYSE: DBD) from Neutral to Outperform with a price target of $5.00.
For an analyst ratings summary and ratings history on Diebold click here. For more ratings news on Diebold click here.
Shares of Diebold closed at $2.49 yesterday.
You May Also Be Interested In
- Goldman Sachs upgrades Sirius XM Radio to Buy with $37 target
- Raymond James Upgrades Lumentum (LITE) to Strong Buy, 'Overreaction to Marvell Offer'
- JPMorgan Upgrades EVgo, Inc. (EVGO) to Neutral
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
